CRA Insights: A landscape assessment of newborn screening (NBS) in Europe
Newborn screening (NBS) has become an integral part of many public health programs.1 NBS programs have minimized patient suffering which results from extended...
Industries
Healthcare
CRA combines in-depth industry knowledge and cutting-edge analytics to evaluate issues being litigated and debated in the healthcare sector. Our industry knowledge enables us to explain, for example, the nuances of provider reimbursement or the patient incentives created by high deductible health insurance plans, and our economic, statistical, accounting, investigative, and finance skills—as well as our familiarity with key healthcare datasets—equips CRA to provide rigorous, defensible analyses tailored to the specific facts of a litigation or regulatory dispute.
Our experts have broad and deep experience in the healthcare sector including hospitals, physician practices, health insurance and health benefit plans, ACOs, PBMs, wholesalers, pharmacies, pharmaceuticals and biologicals, medical devices, clinical laboratories, dialysis facilities, ambulance transport, nursing homes, and home healthcare.
Engagements
- 01European Commission clears Cooper’s acquisition of Viatris’ European OTC businessThe transaction involved a number of horizontal overlaps in areas including antiseptics and disinfectants, laxatives, warts and corns, joint and muscular pain,...View engagement
- 02ITC Section 337 trial testimony on domestic industry for consumer wearable health monitoring technologyCRA’s Intellectual Property experts were retained by a global medical technology and consumer electronics company, to evaluate the economic prong of domestic...View engagement
- 03Lost profits, reasonable royalty damages analysis for respiratory-related medical devicesCRA’s Intellectual Property experts were retained by a multinational developer and manufacturer of respiratory-related medical devices to determine economic...View engagement
Contact a Healthcare expert.
See all Healthcare expertsRecent events
AHLA's The Complexities of AI in Health Care
Kristopher Hult is a panelist during the session titled “Writing on the Wall: What We Can Learn from Case Law and Enforcement Trends When AI Regulation Remains...
World Orphan Drug Congress Europe 2023
CRA is a proud sponsor of the event. Bhavesh Patel and Charlotte Poon present the session titled “Access Opportunities for Rare Disease In and Out of Europe.”...